FdaApplication
NDA 217639
Identifiers
- fda_app_no: NDA217639
Properties
| Property | Value |
|---|---|
| applicant_name | STEMLINE THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2023-01-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORSERDU | ELACESTRANT HYDROCHLORIDE | EQ 86MG BASE | TABLET;ORAL |
| ORSERDU | ELACESTRANT HYDROCHLORIDE | EQ 345MG BASE | TABLET;ORAL |
2 products